Literature DB >> 2866969

Intrathecal DSP4 selectively depletes spinal noradrenaline and attenuates morphine analgesia.

F X Zhong, X Q Ji, K Tsou.   

Abstract

The noradrenergic neurotoxin DSP4 was injected intrathecally into the lumbar spinal subarachnoid space of the rat. After 10 days, dose-response curves for tail-flick inhibition were determined for both intraperitoneal and intraventricular injections of morphine. In rats pretreated with DSP4, the analgesic effect of morphine given either intraventricularly or intraperitoneally was significantly attenuated. The noradrenaline and 5-hydroxytryptamine contents in the brain-stem and the spinal cord were also measured. Intrathecal DSP4 depleted noradrenaline in the spinal cord but not in the brain-stem. Neither brain-stem or spinal cord 5-hydroxytryptamine was affected by DSP4.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2866969     DOI: 10.1016/0014-2999(85)90171-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  The NK1 receptor mediates both the hyperalgesia and the resistance to morphine in mice lacking noradrenaline.

Authors:  Luc Jasmin; Duc Tien; David Weinshenker; Richard D Palmiter; Paul G Green; Gabriella Janni; Peter T Ohara
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

2.  Evidence for crosstolerance to the analgesic effects between morphine and selective alpha 2-adrenoceptor agonists.

Authors:  C Post; T Archer; B G Minor
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

3.  A greater role for the norepinephrine transporter than the serotonin transporter in murine nociception.

Authors:  F S Hall; J M Schwarzbaum; M T G Perona; J S Templin; M G Caron; K-P Lesch; D L Murphy; G R Uhl
Journal:  Neuroscience       Date:  2010-12-01       Impact factor: 3.590

4.  The catecholaminergic neurotransmitter system in methylmercury-induced neurotoxicity.

Authors:  Marcelo Farina; Michael Aschner; João Batista Teixeira da Rocha
Journal:  Adv Neurotoxicol       Date:  2017-09-01

5.  Neonatal DSP-4 treatment modifies antinociceptive effects of the CB1 receptor agonist methanandamide in adult rats.

Authors:  Eva Korossy-Mruk; Katarzyna Kuter; Przemysław Nowak; Ryszard Szkilnik; Monika Rykaczewska-Czerwinska; Richard M Kostrzewa; Ryszard Brus
Journal:  Neurotox Res       Date:  2012-04-10       Impact factor: 3.911

6.  Dual allosteric modulation of opioid antinociceptive potency by α2A-adrenoceptors.

Authors:  Anne-Julie Chabot-Doré; Magali Millecamps; Lina Naso; Dominic Devost; Phan Trieu; Marjo Piltonen; Luda Diatchenko; Carolyn A Fairbanks; George L Wilcox; Terence E Hébert; Laura S Stone
Journal:  Neuropharmacology       Date:  2015-08-06       Impact factor: 5.250

7.  Restoring Spinal Noradrenergic Inhibitory Tone Attenuates Pain Hypersensitivity in a Rat Model of Parkinson's Disease.

Authors:  Lei-Fang Cao; Xiao-Yan Peng; Ya Huang; Bing Wang; Feng-Ming Zhou; Ruo-Xiao Cheng; Li-Hua Chen; Wei-Feng Luo; Tong Liu
Journal:  Neural Plast       Date:  2016-09-26       Impact factor: 3.599

8.  Retrograde adenoviral vector targeting of nociresponsive pontospinal noradrenergic neurons in the rat in vivo.

Authors:  Patrick W Howorth; Anja G Teschemacher; Anthony E Pickering
Journal:  J Comp Neurol       Date:  2009-01-10       Impact factor: 3.215

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.